重大事件
即時報告
8-K
2026-07-23
Ultralife股東年會通過四項提案 高管薪酬投票改為每三年一次
AI 繁中摘要
📄 **申報類型：8-K**
**公司：Ultralife Corporation（代號：ULBI）**
**報告日期：2026年7月23日（事件發生日期：2026年7月22日股東年會）**
Ultralife Corporation 於2026年7月22日舉行年度股東大會，會上通過了四項提案，投票結果已呈交SEC。截至記錄日（5月28日），已發行普通股共16,656,669股，出席（含委託投票）13,980,794股，達83.93%法定人數。
### 📌 重點投票結果
**1. 選舉五名董事（任期一年）**
全部董事均獲通過，惟部分董事有較多反對票：
- Michael E. Manna：贊成11,065,320 / 反對215,149 / 經紀人未投票2,700,325
- Janie Goddard：贊成10,260,448 / 反對1,020,021（反對票較多）
- Thomas L. Saeli、Robert W. Shaw II、Bradford T. Whitmore 贊成票均逾1,090萬
**2. 批准2026年度獨立註冊會計師事務所：WithumSmith+Brown, PC**
贊成13,830,508 / 反對137,166 / 棄權13,120，大比數通過 ✅
**3. 諮詢性高管薪酬投票（Say-on-Pay）**
贊成10,970,705 / 反對245,370 / 棄權64,394 / 經紀人未投票2,700,325，獲通過。
**4. 諮詢性高管薪酬投票頻率（Say-on-Frequency）**
股東偏好「每3年一次」：
- 1年：2,576,450
- 2年：109,411
- 3年：8,554,151（最多）
- 棄權：40,457
董事會根據投票結果及相關因素，決定未來就高管薪酬進行諮詢投票的頻率定為 **每三年一次**。
### 💡 對投資者的潛在影響
股東大會所有提案均順利通過，顯示投資者對現有管理層及審計安排信心充足。其中Janie Goddard獲1,020,021反對票，值得關注，但整體董事會組成未變。未來高管薪酬投票改為三年一次，反映公司傾向較長評估週期，與業界常見做法一致，短期內不會對股價構成重大影響。
展開英文正文
ulbi20260723_8k.htm false 0000875657 0000875657 2026-07-23 2026-07-23 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 July 23, 2026 Date of Report (Date of Earliest Event Reported) ULTRALIFE CORPORATION (Exact name of registrant as specified in its charter) Delaware 000-20852 16-1387013 (State of incorporation) (Commission File Number) (IRS Employer Identification No.) 2000 Technology Parkway, Newark, New York 14513 (Address of principal executive offices) (Zip Code) (315) 332-7100 (Registrant’s telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common Stock, $0.10 par value per share ULBI NASDAQ Stock Market Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934. Emerging Growth Company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 5.07 Submission of Matters to a Vote of Security Holders. On July 22, 2026, Ultralife Corporation (“the Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”). Only stockholders of record at the close of business on May 28, 2026 (the “Record Date”) were entitled to vote at the Annual Meeting. As of the Record Date, there were 16,656,669 shares of common stock outstanding and entitled to vote, of which 13,980,794 (83.93%) were present in person or by proxy, representing a quorum. The results of stockholder voting on the proposals presented were as follows: 1. The Company’s stockholders elected five Directors, all of whom constitute the Company’s entire Board of Directors, to serve for a term of one year and until their successors are duly elected and qualified. The number of shares that (i) voted for the election of each Director, (ii) withheld authority to vote for each Director, and (iii) were broker non-votes, are set forth in the table below. Director For Withheld Broker Non-Votes Michael E. Manna 11,065,320 215,149 2,700,325 Janie Goddard 10,260,448 1,020,021 2,700,325 Thomas L. Saeli 11,044,346 236,123 2,700,325 Robert W. Shaw II 11,044,375 236,094 2,700,325 Bradford T. Whitmore 10,912,209 368,260 2,700,325 2. The Company’s stockholders ratified the selection of the Company’s independent registered public accounting firm as WithumSmith+Brown, PC for 2026. The number of shares that (i) voted for the ratification of the accounting firm, (ii) voted against the ratification, and (iii) abstained from the vote are set forth in the table below. For Withheld Abstain 13,830,508 137,166 13,120 3. The Company’s shareholders approved an advisory resolution on executive compensation. The number of shares that (i) voted for the resolution, (ii) voted against the resolution, (iii) abstained from the vote, and (iv) were broker non-votes, are set forth in the table below. For Against Abstain Broker Non-Votes 10,970,705 245,370 64,394 2,700,325 4. The Company’s shareholders indicated their preference, on a non-binding advisory basis, that the frequency of future advisory votes on executive compensation be “3 Years”. The number of shares that (i) voted for 1 Year, (ii) voted for 2 Years, (iii) voted for 3 Years, and (iv) abstained from the vote, are set forth in the table below. 1 Year 2 Years 3 Years Abstain 2,576,450 109,411 8,554,151 40,457 In consideration of the voting results of the Annual Meeting and other factors, the Board of Directors has determined that the frequency of future advisory votes on executive compensation will be three years. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: July 23, 2026 ULTRALIFE CORPORATION By: /s/ Philip A. Fain Philip A. Fain Chief Financial Officer and Treasurer